Literature DB >> 18344637

Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach.

Girolamo Catapano-Minotti1, Andrea Corsonello, Giovanni Guadalupi, Rosalia Spani, Raffaele Antonelli-Incalzi.   

Abstract

We present a case of scleroderma complicated by severe pulmonary hypertension. The use of a three-drug (bosentan, iloprost, and sildenafil) approach contributed to significant improvement of both the clinical conditions and the pulmonary hemodynamics. Combining three pulmonary vasodilators with different mechanisms of action could benefit patients with severe pulmonary hypertension resistant to conventional therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344637     DOI: 10.2169/internalmedicine.47.0565

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

Review 1.  Targeted therapy for systemic sclerosis: how close are we?

Authors:  Manuel Ramos-Casals; Vicent Fonollosa-Pla; Pilar Brito-Zerón; Antoni Sisó-Almirall
Journal:  Nat Rev Rheumatol       Date:  2010-04-13       Impact factor: 20.543

2.  Potential effect of Sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis.

Authors:  Tamer A Gheita; Hussam Ammar; Sanaa A Kenawy
Journal:  Springerplus       Date:  2014-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.